Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
266 results found
2025 ∙ Ngamprasertchai, T. Ruenroengbun, N. Kajeekul, R.
Immunogenicity and Safety of the Higher-Valent Pneumococcal Conjugate Vaccine vs the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Adults Older adults Pneumococcal disease Efficacy/effectiveness Safety Administration
Rating:
Low
2025 ∙ Cho, J. Y. Lee, H. Wannaadisai, W. Vietri, J. Chaiyakunapruk, N.
Systematic literature review of cost-effectiveness analyses of adult 15- and 20-valent pneumococcal vaccines
Adults Older adults Pneumococcal disease Economic aspects
Rating:
Not applicable
2025 ∙ SAGE
Meeting of the Strategic Advisory Group of Experts on Immunization, March 2025: Conclusions and recommendations
Meeting report Pneumococcal disease Mpox Herpes zoster Poliomyelitis
Download:
2024 ∙ Silverii, G. A. Gabutti, G. Tafuri, S. Sarti, F. Pratesi, A. Clerico, A. Fornengo, R. Greco, C. Irace, C. Sordi, V. Sorice, G. P. Cavallo, M. Ponziani, M. C. Mannucci, E. Dicembrini, I.
Diabetes as a risk factor for pneumococcal disease and severe related outcomes and efficacy/effectiveness of vaccination in diabetic population. Results from meta-analysis of observational studies
Adults Pneumococcal disease Efficacy/effectiveness
Rating:
High
2024 ∙ Gebreyesus, A. Tesfay, K.
Effect of maternal education on completing childhood vaccination in Ethiopia: systematic review and meta-analysis
Africa Ethiopia Children Tuberculosis Poliomyelitis Diphtheria Tetanus Hepatitis B Haemophilus influenzae type B Pneumococcal disease Measles Coverage
Rating:
Not applicable
2024 ∙ Sepúlveda-Pachón, I. T. Dunne, E. M. Hanquet, G. Baay, M. Menon, S. Jodar, L. Gessner, B. D. Theilacker, C.
Effect of pneumococcal conjugate vaccines on viral respiratory infections: a systematic literature review
All age groups Pneumococcal disease Efficacy/effectiveness
Rating:
Moderate
2024 ∙ Grant, L. R. Hanquet, G. Sepulveda-Pachon, I. T. Theilacker, C. Baay, M. Slack, M. P. E. Jodar, L. Gessner, B. D.
Effects of PCV10 and PCV13 on pneumococcal serotype 6C disease, carriage, and antimicrobial resistance
All age groups Pneumococcal disease Efficacy/effectiveness
Rating:
Critically low
2024 ∙ Wagner, G. Gartlehner, G. Thaler, K. Ledinger, D. Feyertag, J. Klerings, I. Saif-Ur-Rahman, K. M. Devane, D. Olsson, K. Adel Ali, K. Vygen-Bonnet, S. Salo, H. Zavadska, D. Grgic Vitek, M. Oona, M. Cunney, R. Tuerlinckx, D. Kristensen Lomholt, F. Sommer, I.
Immunogenicity and safety of the 15-valent pneumococcal conjugate vaccine, a systematic review and meta-analysis
All age groups Pneumococcal disease Efficacy/effectiveness Safety Administration
Rating:
Moderate
2024 ∙ Feng, S. McLellan, J. Pidduck, N. Roberts, N. Higgins, J. P. Choi, Y. Izu, A. Jit, M. Madhi, S. A. Mulholland, K. Pollard, A. J. Procter, S. Temple, B. Voysey, M.
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis
Newborn Children Pneumococcal disease Efficacy/effectiveness Administration
Rating:
Critically low
2024 ∙ Beetch, J. E. Janitz, A. Beebe, L. A. Gowin, M. Xu, C. Clifton, S. Kuhn, K. G.
Indirect Effects of the COVID-19 Pandemic on Routine Childhood Vaccination in Low-Income Countries: A Systematic Review to Set the Scope for Future Pandemics
Newborn Children Adolescents Low and Middle Income Countries Tuberculosis Poliomyelitis Diphtheria Pertussis Tetanus Hepatitis B Haemophilus influenzae type B Pneumococcal disease Rotavirus Measles Rubella Malaria Yellow fever Coverage
Rating:
Not applicable
Loading...